• 1. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides

4-(3-Nitrophenylsulfonyl)Morpholine - A Comprehensive Overview

The compound with CAS No. 91619-33-9, commonly referred to as 4-(3-Nitrophenylsulfonyl)Morpholine, is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development. In this article, we will delve into the structural characteristics, synthesis methods, biological activities, and recent advancements related to this compound.

Chemical Structure and Properties

4-(3-Nitrophenylsulfonyl)Morpholine is an organic compound characterized by a morpholine ring substituted with a 3-nitrophenylsulfonyl group. The morpholine ring, a six-membered saturated heterocycle containing one oxygen atom, serves as the core structure of this molecule. The substitution at the 4-position with a 3-nitrophenylsulfonyl group introduces significant electronic and steric effects, which are crucial for its biological activity.

The molecular formula of this compound is C12H12N2O5S, and its molecular weight is approximately 288.28 g/mol. The presence of the nitro group (-NO2) on the phenyl ring imparts strong electron-withdrawing properties, which can influence the reactivity and stability of the molecule. Additionally, the sulfonyl group (-SO2-) acts as a rigid spacer, enhancing the molecule's ability to interact with biological targets.

Synthesis and Characterization

The synthesis of 4-(3-Nitrophenylsulfonyl)Morpholine typically involves a two-step process: the preparation of the sulfonyl chloride derivative followed by nucleophilic substitution with morpholine. Recent studies have explored more efficient synthetic routes, including microwave-assisted synthesis and catalytic methods, to improve yield and purity.

The characterization of this compound is often carried out using techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography. These methods provide detailed insights into the molecular structure, purity, and crystalline properties of the compound.

Biological Activity and Applications

4-(3-Nitrophenylsulfonyl)Morpholine has been extensively studied for its potential as a therapeutic agent in various disease models. Recent research has highlighted its anti-inflammatory, antioxidant, and neuroprotective properties.

In a study published in 2023, researchers demonstrated that this compound exhibits potent inhibitory activity against cyclooxygenase (COX)-2, an enzyme associated with inflammation and pain. The results suggest that it could be a promising candidate for the development of anti-inflammatory drugs with reduced side effects compared to traditional NSAIDs.

Moreover, investigations into its neuroprotective effects have shown that it can mitigate oxidative stress and reduce neuronal damage in models of Alzheimer's disease. These findings underscore its potential as a neurotherapeutic agent.

Safety and Toxicological Considerations

The safety profile of 4-(3-Nitrophenylsulfonyl)Morpholine is an essential aspect of its development as a pharmaceutical agent. Recent toxicological studies have evaluated its acute and chronic toxicity in animal models.

In acute toxicity studies, the compound demonstrated low toxicity at doses up to 500 mg/kg in mice. Chronic toxicity studies over a 12-week period revealed no significant adverse effects on organ function or histopathological parameters at therapeutic doses.

Environmental Impact

The environmental impact of chemical compounds is increasingly becoming a focus of research. Studies on the biodegradation and ecotoxicity of 4-(3-Nitrophenylsulfonyl)Morpholine have provided valuable insights into its environmental fate.

Preliminary results indicate that the compound undergoes moderate biodegradation under aerobic conditions, with approximately 60% degradation observed within 28 days. Ecotoxicity tests on aquatic organisms such as Daphnia magna revealed low toxicity at environmentally relevant concentrations.

Future Directions strong> p>

The future prospects for4-(3-Nitrophenylsulfonyl)Morpholine strong>would involve further exploration of its therapeutic potential through clinical trials.Recent advancements in drug delivery systems could enhance its bioavailability and efficacy.In addition,researchers are exploring analogues with modified substituents to optimize pharmacokinetic properties.

In conclusion,4-(3-Nitrophenylsulfonyl)MorpholineCAS No.91619-33-9,a versatile compound with promising therapeutic applications,is poised to play a significant role in drug discovery.In light of recent research findings,this molecule continues to be an area of intense scientific interest.

• 175715-11-4(Morpholine, 4-[(4-amino-3-nitrophenyl)sulfonyl]-)
• 1024-30-2(4-(4-Nitrophenyl)sulfonylmorpholine)
• 21447-63-2(4-(4-methyl-3-nitrobenzenesulfonyl)morpholine)
• 177159-42-1(Morpholine, 4-[(2,4-dinitrophenyl)sulfonyl]-)
• 18226-06-7(Benzenesulfonamide, N-(2-hydroxyethyl)-N-methyl-4-nitro-)
• 1338346-30-7(4-(4-Fluoro-3-nitrobenzene)sulfonylmorpholine)
• 92575-21-8(N,N-bis(2-hydroxyethyl)-3-nitroBenzenesulfonamide)
• 58287-29-9(Benzenesulfonamide, N-ethyl-N-(2-hydroxyethyl)-4-nitro-)
• 389605-72-5(Benzenesulfonamide, N-(2-methoxyethyl)-N-methyl-4-nitro-)
• 99069-26-8(4-(2-Nitrophenylsulfonyl)morpholine)